Home › Research › Prevention trials
The Role of Phytochemicals in Age-Related Cognitive Decline: A Natural Solution for Brain Health
Esther Ugo Alum, Daniel Ejim Uti, Simeon Ikechukwu Egba, Okechukwu Paul-Chima Ugwu, Patrick Maduabuchi Aja. Natural Product Communications, 2025-06-01
Topic: Risk, prevention and care in population studies
Plain-language summary
Age-related cognitive decline, characterized by memory loss, attention deficits, and reduced executive function, remains a major public health challenge, with limited pharmaceutical interventions offering symptomatic relief. Phytochemicals, bioactive compounds derived from plants, have emerged as promising neuroprotective agents due to their antioxidant, anti-inflammatory, and neurogenic properties. This review explores the role of phytochemicals in mitigating cognitive deterioration through in vitro, in vivo, and clinical studies. Key compounds such as flavonoids, curcumin, resveratrol, and Ginkgo biloba derived compounds including; Ginkgolic Acids, terpenoids (Ginkgolides and Bilobalide), have demonstrated potential in reducing oxidative stress, modulating neuroinflammation, enhancing mitochondrial function, and improving neurotransmitter balance. However, challenges such as bioavailability, dose optimization, and clinical translation hinder their widespread adoption. Advances in delivery technologies, including nanoencapsulation and liposomal formulations, may enhance their therapeutic efficacy. Additionally, integrative strategies combining phytochemical-rich diets with lifestyle interventions, such as the Mediterranean and MIND diets, present a holistic approach to cognitive health. While preliminary findings are promising, further large-scale clinical trials are needed to validate the efficacy of phytochemicals in preventing and treating age-related cognitive decline. Understanding their mechanisms and overcoming translational barriers will facilitate their integration into mainstream healthcare as sustainable, natural alternatives to pharmacological treatments. By leveraging the neuroprotective potential of phytochemicals, future interventions could provide accessible and effective solutions for promoting brain health in aging populations.
What this study adds
Evidence grade: Low
This review describes plant compounds such as flavonoids, curcumin, resveratrol, and Ginkgo biloba components that show antioxidant, anti-inflammatory, and other potentially protective effects in laboratory and some clinical studies. It notes challenges with bioavailability and dose, and states that large-scale clinical trials are still needed before these can be recommended.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Alum, E. U., Uti, D. E., Egba, S. I., Ugwu, O. P.-C., & Aja, P. M. (2025). The Role of Phytochemicals in Age-Related Cognitive Decline: A Natural Solution for Brain Health. Natural Product Communications. https://doi.org/10.1177/1934578x251350761
Vancouver
Alum EU, Uti DE, Egba SI, Ugwu OP.-C, Aja PM. The Role of Phytochemicals in Age-Related Cognitive Decline: A Natural Solution for Brain Health. Natural Product Communications. 2025. doi:10.1177/1934578x251350761.
BibTeX
@article{alum2025-a534c305,
author = {Alum, Esther Ugo and Uti, Daniel Ejim and Egba, Simeon Ikechukwu and Ugwu, Okechukwu Paul-Chima and Aja, Patrick Maduabuchi},
title = {{The Role of Phytochemicals in Age-Related Cognitive Decline: A Natural Solution for Brain Health}},
journal = {Natural Product Communications},
year = {2025},
doi = {10.1177/1934578x251350761},
url = {https://doi.org/10.1177/1934578x251350761}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Key compounds such as flavonoids, curcumin, resveratrol, and Ginkgo biloba derived compounds including; Ginkgolic Acids, terpenoids (Ginkgolides and Bilobalide), have demonstrated potential in reducing oxidative stress, modulating neuroinflammation, enhancing mitochondrial function, and improving neurotransmitter balance.
Why it matters
This review describes plant compounds such as flavonoids, curcumin, resveratrol, and Ginkgo biloba components that show antioxidant, anti-inflammatory, and other potentially protective effects in laboratory and some clinical studies. It notes challenges with bioavailability and dose, and states that large-scale clinical trials are still needed before these can be recommended.
New to this subject? Start with our plain-English guide: Prevention →
Study details
- Evidence strengthLow
How this study scored 35/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Natural Product Communications) |
| Journal's citation record | 0 / 4 | Natural Product Communications: journal h-index 73 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 7 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 2.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 3 / 6 | Cited 7.4× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 7 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Patrick Maduabuchi Aja: h-index 26 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Ebonyi State University: institution h-index 104 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 2 countries |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 2 / 2 | Free to read |
| Total | 35 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Prevention trials from nearby years
Also tagged “decline”
1,116 studies in the library carry the topic tag “decline”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,116 tagged studies.